Forte Biosciences, Inc. (FBRX): auditor change — Forte Biosciences appoints KPMG as new independent auditor for FY2023

Forte Biosciences, Inc.

Audit Committee approved KPMG LLP as independent registered public accounting firm for fiscal year ending Dec 31, 2023.
Prior auditor Mayer Hoffman McCann P.C. (MHM) declined reappointment on July 31, 2023.
No disagreements or reportable events occurred during previous fiscal years or interim period through Dec 4, 2023.

item 4.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Forte Biosciences, Inc. engaged KPMG LLP as its auditor.

Action: engagement
Auditor: KPMG LLP

Exact text from the filing

On December 4, 2023, the Audit Committee approved the appointment of KPMG LLP ("KPMG") as the Company's new independent registered public accounting firm for the fiscal year ending December 31, 2023.

View on SEC.gov

Browse all auditor changes →

Forte Biosciences, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-291670

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.